Brief: Axsome Therapeutics Settles Sunosi Patent Litigation With Hetero Labs
27/05/2025 13:12
May 27 (Reuters) - Axsome Therapeutics Inc AXSM.O: AXSOME THERAPEUTICS SETTLES SUNOSI® (SOLRIAMFETOL) PATENT LITIGATION WITH HETERO LABS LTD. AXSOME - HETERO TO SELL GENERIC SUNOSI FROM SEPT 1, 2040 IF PEDIATRIC EXCLUSIVITY IS GRANTED FOR SUNOSI Source text: ID:nGNX8KYYTc Further company coverage: AXSM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axsome Therapeutics
See all newsUS RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth